Cognition, Metacognition, and Stigma in Patients With Suicidal Ideation
NCT ID: NCT06652815
Last Updated: 2025-12-02
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
220 participants
OBSERVATIONAL
2026-03-01
2027-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Executive Dysfunction and Suicide in Psychiatric Outpatients and Inpatients
NCT01043432
Executive Dysfunction & Suicide: An Exploration Of Risk Factors In Traumatically Brain Injured Veterans
NCT01118195
Evaluating the Effectiveness of Treatment for Metacognition in Moderate and Severe Traumatic Brain Injury
NCT03169647
Cognitive Inhibition, Psychosocial Interactions and Suicide Attempt in Elderly
NCT02858427
Cognitive Training to Promote Brain Health: Implementation and Engagement
NCT03408509
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Executive functioning and Suicide Studies reported that deficits in some executive functions are correlated with an elevated risk for suicide attempts. Executive dysfunction may interfere with an individual's ability to understand that they are at risk for suicide as well as with their ability to cope with that risk. Although past studies have identified the role of cognitive factors in suicide, little has been done to explore the cognitive processes involved in suicidal thinking in adults (Ong et al. 2016). Neuropsychological alterations can lead to inaccurate perception, interpretation, and response to environmental information, which could be a risk factor for suicide (Fernández-Sevillano et al. 2021).
Metacognition is an essential process regarding decision making and coping with stressful life events. It describes the awareness of person's cognitions in relation to suicide (thoughts, beliefs and attributions). The suicidal person feels helpless and decides that death is only solution. The person has narrowed all his/her options solely to death. Knowing these patterns will give some guidance in talking to a suicidal person. It is significant for assessing to try to accept and understand feelings "meta-emotion" and thought/attributions "meta-cognition" the person is expressing (Abdulla et al. 2018).
Stigma is most often defined as a mark of disgrace or infamy; a stain or reproach, as on one's reputation. In suicide investigators talk about public and self-stigma. Both forms of stigma can separately cause social isolation, demoralization, hopelessness and other consequences that interfere with the previous functioning. Because of the high incidence of psychological changes after stigma it is crucial for the bereaved to have close mental health services. But stigma is a barrier to treatment seeking. After suicide attempt most survivors feel stigmatized but it is not yet known which factors modify the perception of stigma (Sabina et al. 2017).
The purpose of the present study is to explore the relationships between executive functioning metacognition, and stigma in suicidal ideation and suicide attempters in the Indian setup, where there is a lacuna in research regarding the same.
Research questions
* What is the executive functioning, metacognitive beliefs, and stigma in persons with high suicide ideation or attempts?
* Is there any relationship among executive functioning, metacognitive beliefs, and stigma in these individuals? Hypotheses There will be a relationship among executive functioning, metacognitive beliefs, and stigma in persons with high suicide ideation or attempts.
Objective To assess the executive functioning, metacognitive beliefs, and stigma in persons with high suicide ideation or attempts.
To study the relationship among executive functioning, metacognitive beliefs, and stigma in persons with high suicide ideation or attempts.
Methodology Samples size: Total number of sample for this study will be N=212. The sample size 212 was calculated on the basis of estimated population of 1000 using Epitools online sample size calculator (https://epitools.ausvet.com.au/oneproportion) , and Confidence level was 0.95, with Desired precision of estimate=0.05.
Sampling: Probability sampling (Simple random sampling (Every Individual with high suicide ideation or suicide attempts visiting to ABVIMS -Dr. RML Hospital for treatment will be screened for this study.
The present study is a cross sectional study. For the purpose of this study, individuals with suicidal ideation and attempts who are seeking treatment at the outpatient department of Psychiatry, as well as medical emergency of Dr. RML Hospital or referred to Department of Clinical Psychology would be approached to participate in the study.
After establishing the rapport, diagnostic clarifications (ICD-10) and screening for high suicide ideation using Beck Scale for Suicidal Ideation (BSSI), inclusion and exclusion criteria will be applied. Participant who fulfils inclusion criteria will be introduced to the study details, then they will be explained about the purpose of the study and its associated aspects and informed consent will be taken. Their socio- demographics details will also be gathered. Following this Depression, Anxiety and Stress Scale (DASS-21), Wisconsin Card Sorting Test (WCST), Metacognitions Scale (MCQ-30) and Stigma of Suicide Scale (SOSS) will be administered.
All the data will be kept confidential in lock and key and using password protected files. Once all the assessment will be completed data entry in excel sheets will be done and analysis of the data will be done using appropriate SPSS statistical package. After all the analysis completed result and discussion of the study will be prepared.
Detail of tools to be used:
1. ICD-10 Research diagnostic criteria
2. Socio-demographic and clinical data sheet
3. Depression, Anxiety and Stress Scale-21 Items (DASS-21)
4. Beck Scale for Suicidal Ideation (BSSI)
5. Wisconsin Card Sorting Test (WCST)
6. Metacognitions Scale (MCQ-3)
7. Stigma of Suicide Scale (SOSS)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Persons with suicide attempt or suicide ideation
Individuals with high suicide ideation or suicide attempts visiting ABVIMS -Dr. RML Hospital for treatment will be screened for this study.
Suicide ideation or suicide attempt
Individuals with high suicide ideation or suicide attempts visiting ABVIMS -Dr. RML Hospital for treatment will be screened for this study. socio- demographics details will also be gathered. Following this Depression, Anxiety and Stress Scale (DASS-21), Wisconsin Card Sorting Test (WCST), Metacognitions Scale (MCQ-30) and Stigma of Suicide Scale (SOSS) will be administered.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Suicide ideation or suicide attempt
Individuals with high suicide ideation or suicide attempts visiting ABVIMS -Dr. RML Hospital for treatment will be screened for this study. socio- demographics details will also be gathered. Following this Depression, Anxiety and Stress Scale (DASS-21), Wisconsin Card Sorting Test (WCST), Metacognitions Scale (MCQ-30) and Stigma of Suicide Scale (SOSS) will be administered.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Age between 18 to 60 years.
* Able to read and write in Hindi and English
* With a primary mental health diagnosis of anxiety, depression, acute stress reaction or adjustment disorder, or with no diagnosis at all
* Persons with high suicidal ideation (Score 2 or more in first five items of BSSI)
* Person who attempted suicide in last three months.
Exclusion Criteria
* Diagnosis of a major mental disorder such as Schizophrenia or Bipolar Affective Disorder.
* Intellectual Disability and neurological disorder.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fogarty International Center of the National Institute of Health
NIH
University of Pittsburgh
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Vishwajit Nimgaonkar, MD PhD
Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Vishwajit L Nimgaonkar, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Pittburgh
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
STUDY23010161
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.